InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-07 · accession 0001415889-25-012532 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-05-09 2025-05-07 KNSA Megna Michael R CAO M - OptEx $12.53 +17.6K 50.2K +54% +$221.1K
D 2025-05-09 2025-05-07 KNSA Megna Michael R CAO S - Sale+OE $26.69 -17.6K 32.5K -35% -$471.0K
DM 2025-05-09 2025-05-07 KNSA Megna Michael R CAO M - OptEx $0.00 -17.6K 16.0K -52% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Share 2025-05-07 M A 229 $8.83 32,775 D — —
2 Common Class A Ordinary Share 2025-05-07 M A 2,998 $15.50 35,773 D — —
3 Common Class A Ordinary Share 2025-05-07 S D 17,647 $26.69 32,546 D — —
4 Common Class A Ordinary Share 2025-05-07 M A 14,420 $11.97 50,193 D — —
5 Derivative Share Option 2025-05-07 M D 229 $0.00 0 D $8.83 · — to — 229 Class A Ordinary Share (F2) The option is fully vested and exercisable.
6 Derivative Share Option 2025-05-07 M D 14,420 $0.00 17,040 D $11.97 · — to 2032-08-31 14,420 Class A Ordinary Share (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
7 Derivative Share Option 2025-05-07 M D 2,998 $0.00 16,002 D $15.50 · — to — 2,998 Class A Ordinary Share (F2) The option is fully vested and exercisable.